Product Review Opportunity for: Salinex ProTect® Nasal Spray - Winter 2025
Winter is a time when we spend a lot of time indoors with our loved ones, sharing a meal, sharing some laughs... and sometimes sharing some germs!
Salinex ProTect® Nasal Spray is clinically proven* to reduce viral load in your nostrils, offering a triple-action defense mechanism against viruses such as the common cold and upper respiratory infections when used early or at the onset of symptoms. Salinex ProTect® forms a protective barrier in the nasal passages, inhibiting viral replication to reduce the duration of your illness if you do happen to become sick. To be sure this product is right for you, always read and follow the label.
- Antiviral effects which protect against the transmission of viral infectious diseases like the common cold
- Provides symptomatic relief of cold symptoms such as nasal congestion and runny nose and helps to moisten dry nasal mucosa without feeling sleepy or lethargic
- Gentle product that does not cause addiction or dependence, suitable for daily use
- Preservative free
- Suitable for adults and children over one year old
This product contains Iota-Carrageenan 1.2 mg and sodium chloride (salt) 0.5%, and water, so you can feel good about rinsing away viruses before they have a chance to infect your nasal lining.
- Spray one dose into each nostril as part of your daily hygiene regimen up to 3 times daily.
If you'd like to give this product a try, please complete the short survey below. Opportunity is open to residents of Canada only.
*A study1 has shown that Salinex ProTect® is effective when used within 48 hours of the onset of cold symptoms. The viral load in the nasal cavities of subjects having used Salinex ProTect® at an early stage was reduced by 92% after the 3rd and 4th days. In this same period, subjects who were given a placebo experienced a viral load increase of 579%.
Source: 1Eccles R. et al. Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold. Journal of Respiratory Research. 2010; 11:108-117.
You must be logged in to complete this.
Product Review Opportunity for: Salinex ProTect® Nasal Spray - Winter 2025
Winter is a time when we spend a lot of time indoors with our loved ones, sharing a meal, sharing some laughs... and sometimes sharing some germs!
Salinex ProTect® Nasal Spray is clinically proven* to reduce viral load in your nostrils, offering a triple-action defense mechanism against viruses such as the common cold and upper respiratory infections when used early or at the onset of symptoms. Salinex ProTect® forms a protective barrier in the nasal passages, inhibiting viral replication to reduce the duration of your illness if you do happen to become sick. To be sure this product is right for you, always read and follow the label.
- Antiviral effects which protect against the transmission of viral infectious diseases like the common cold
- Provides symptomatic relief of cold symptoms such as nasal congestion and runny nose and helps to moisten dry nasal mucosa without feeling sleepy or lethargic
- Gentle product that does not cause addiction or dependence, suitable for daily use
- Preservative free
- Suitable for adults and children over one year old
This product contains Iota-Carrageenan 1.2 mg and sodium chloride (salt) 0.5%, and water, so you can feel good about rinsing away viruses before they have a chance to infect your nasal lining.
- Spray one dose into each nostril as part of your daily hygiene regimen up to 3 times daily.
If you'd like to give this product a try, please complete the short survey below. Opportunity is open to residents of Canada only.
*A study1 has shown that Salinex ProTect® is effective when used within 48 hours of the onset of cold symptoms. The viral load in the nasal cavities of subjects having used Salinex ProTect® at an early stage was reduced by 92% after the 3rd and 4th days. In this same period, subjects who were given a placebo experienced a viral load increase of 579%.
Source: 1Eccles R. et al. Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold. Journal of Respiratory Research. 2010; 11:108-117.